相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Grading immunohistochemical markers p16INK4a and HPV E4 identifies productive and transforming lesions caused by low- and high-risk HPV within high-grade anal squamous intraepithelial lesions
A. Leeman et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans
P. J. Maver et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study
Frederique J. Vink et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
RNA-based high-risk HPV genotyping and identification of high-risk HPV transcriptional activity in cervical tissues
Corina N. A. M. van den Heuvel et al.
MODERN PATHOLOGY (2020)
Type-Specific Viral Load and Physical State of HPV Type 16, 18, and 58 as Diagnostic Biomarkers for High-Grade Squamous Intraepithelial Lesions or Cervical Cancer
Jongseung Kim et al.
CANCER RESEARCH AND TREATMENT (2020)
Combined assessment of 3q26 amplification and promoter methylation in patients with high grade cervical lesions show age specific differences
Josefine Beiersdorf et al.
GENES CHROMOSOMES & CANCER (2020)
Increased High-Risk Human Papillomavirus Viral Load Is Associated With Immunosuppressed Microenvironment and Predicts a Worse Long-Term Survival in Cervical Cancer Patients
Meng Cao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions
Annemiek Leeman et al.
CANCER MEDICINE (2020)
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix
Saioa Mendaza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cervicovaginal microbiome and natural history of HPV in a longitudinal study
Mykhaylo Usyk et al.
PLoS Pathogens (2020)
Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer
Barbara C. Snoek et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy
Jing Ye et al.
BMC CANCER (2019)
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+in triage of women with minor abnormal cytology
Eliana Peeters et al.
CANCER CYTOPATHOLOGY (2019)
HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme
N. J. Polman et al.
PREVENTIVE MEDICINE (2019)
HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
Helena Frayle et al.
BMC WOMENS HEALTH (2019)
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
Tim Palmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Population-based primary HPV mRNA cervical screening compared with cytology screening
Ylva Lindroth et al.
PREVENTIVE MEDICINE (2019)
Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer
Po-Hsuan Su et al.
SCIENTIFIC REPORTS (2019)
Accuracy of mRNA HPV Tests for Triage of Precursor Lesions and Cervical Cancer: A Systematic Review and Meta-Analysis
Ana Cristina L. Macedo et al.
JOURNAL OF ONCOLOGY (2019)
Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis
Helen Kelly et al.
BRITISH JOURNAL OF CANCER (2019)
HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia
Malin Berggrund et al.
VIROLOGY JOURNAL (2019)
Investigation of Cervical Tumor Biopsies for Chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the HLA II Locus in HIV-1/HPV Co-infected Women
Ramadhani Chambuso et al.
FRONTIERS IN ONCOLOGY (2019)
Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
Clare A. Aitken et al.
BMC MEDICINE (2019)
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial
Nicole J. Polman et al.
LANCET ONCOLOGY (2019)
Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study
Margot M. Koeneman et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women
Wiyada Dankai et al.
PLOS ONE (2019)
Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment A Randomized Clinical Trial
Rachel L. Winer et al.
JAMA NETWORK OPEN (2019)
Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers
Wanxue Xu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Association of p16 (CDKN2A) polymorphisms with the development of HPV16-related precancerous lesions and cervical cancer in the Greek population
Dimitris Tsakogiannis et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer
Yingji Jin et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer
Ana E. Zacapala-Gomez et al.
BMC CANCER (2018)
MicroRNAs as markers of progression in cervical cancer: a systematic review
Barbara Pardini et al.
BMC CANCER (2018)
Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women
Megan A. Clarke et al.
CLINICAL CANCER RESEARCH (2018)
Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples
Wina Verlaat et al.
CLINICAL CANCER RESEARCH (2018)
Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more
A. G. Siebers et al.
CYTOPATHOLOGY (2018)
A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up
M. T. Bruno et al.
EPIDEMIOLOGY AND INFECTION (2018)
Three-tiered score for Ki-67 and p16ink4a improves accuracy and reproducibility of grading CIN lesions
Marjolein van Zummeren et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation
Annemiek Leeman et al.
GYNECOLOGIC ONCOLOGY (2018)
Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples
Andrew Stevenson et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions
Marjolein van Zummeren et al.
MODERN PATHOLOGY (2018)
Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study
Renee M. F. Ebisch et al.
PLOS ONE (2018)
An interaction network driven approach for identifying biomarkers for progressing cervical intraepithelial neoplasia
Shikha Suman et al.
SCIENTIFIC REPORTS (2018)
Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy
Xin Tang et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women
Qiaowen Bu et al.
BMC CANCER (2018)
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
Marc Arbyn et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Cervicovaginal Fungi and Bacteria Associated With Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Infections in a Hispanic Population
Filipa Godoy-Vitorino et al.
FRONTIERS IN MICROBIOLOGY (2018)
HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
Sergio Menezes Amaro-Filho et al.
PAPILLOMAVIRUS RESEARCH (2018)
Diagnostic performance of dual-staining cytology for cervical cancer screening: A systematic literature review
Wiebren A. A. Tjalma
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2017)
Molecular approaches for HPV genotyping and HPV-DNA physical status
D. Tsakogiannis et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2017)
Genotype-specific methylation of HPV in cervical intraepithelial neoplasia
Yaw-Wen Hsu et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue
Eric P. Dixon et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women
Renee M. F. Ebisch et al.
MODERN PATHOLOGY (2017)
High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study
P. J. W. Ketelaars et al.
PREVENTIVE MEDICINE (2017)
Promoter methylation status of the tumor suppressor genes p16 and cadherin 1 in cervical intraepithelial neoplasia
Ruei-Nian Li et al.
ONCOLOGY LETTERS (2017)
Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions
Gislaine Curty et al.
SCIENTIFIC REPORTS (2017)
Concordance of HPV load and HPV mRNA for 16 carcinogenic/possibly carcinogenic HPV types in paired smear/tissue cervical cancer specimens
Gordana Halec et al.
ARCHIVES OF VIROLOGY (2017)
MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
Sunyoung Park et al.
BMC CANCER (2017)
Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer
Yimin Ge et al.
CANCER CYTOPATHOLOGY (2017)
Use of Cytology, E6/E7 mRNA and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening
Daniela Gustinucci et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
The complex relationship between human papillomavirus and cervical adenocarcinoma
Anco Molijn et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Claudin-1 as a Biomarker of Cervical Cytology and Histology
Marta Benczik et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention
Attila T. Lorincz
ACTA CYTOLOGICA (2016)
Association of P16-RBSP3 inactivation with phosphorylated RB1 overexpression in basal-parabasal layers of normal cervix unchanged during CACX development
Chandraditya Chakraborty et al.
BIOCHEMICAL JOURNAL (2016)
Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
Nerea Fontecha et al.
BMC CANCER (2016)
Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring
Georgia Kontostathi et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
Lise M. A. De Strooper et al.
GYNECOLOGIC ONCOLOGY (2016)
The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples
Renee M. F. Ebisch et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none
Mariam El-Zein et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Triage of HPV positive women in cervical cancer screening
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Point-of-care test for cervical cancer in LMICs
Sulma I. Mohammed et al.
ONCOTARGET (2016)
Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study
Sveinung Wergeland Sorbye et al.
BMJ OPEN (2016)
Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology
Ying Liu et al.
SCIENTIFIC REPORTS (2016)
Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care
Adrya Lucia Peres et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
Amplification of the 3q chromosomal region as a specific marker in cervical cancer
Thomas C. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea
H.Y. Oh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes
Viola M. J. Verhoef et al.
GYNECOLOGIC ONCOLOGY (2015)
HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women
Sotirija Duvlis et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM
Heather Griffin et al.
MODERN PATHOLOGY (2015)
HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions
D. Vrdoljak-Mozetic et al.
CYTOPATHOLOGY (2015)
Semi-quantitative HPV viral load in patients with ASC-US cytology: viral load correlates strongly with the presence of CIN but only weakly with its severity
S. J. Lee et al.
CYTOPATHOLOGY (2015)
Amplification of 3q26 and 5p15 regions in cervical intraepithelial neoplasia
Erik Kudela et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2014)
Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study
Albert G. Siebers et al.
CANCER CAUSES & CONTROL (2014)
Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - A systematic review and meta-analysis
Lorenz K. Thomas et al.
EUROPEAN JOURNAL OF CANCER (2014)
Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer
Viola M. J. Verhoef et al.
GYNECOLOGIC ONCOLOGY (2014)
Clinical Performance of Roche Cobas 4800 HPV Test
Miao Cui et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Optimal Positive Cutoff Points for careHPV Testing of Clinician- and Self-Collected Specimens in Primary Cervical Cancer Screening: an Analysis from Rural China
Le-Ni Kang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysis
Dimitris Tsakogiannis et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial
Viola M. J. Verhoef et al.
LANCET ONCOLOGY (2014)
Prognostic Significance of Overexpressed p16INK4a in Patients with Cervical Cancer: A Meta-Analysis
Jiaying Lin et al.
PLOS ONE (2014)
MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
Kouji Banno et al.
SCIENTIFIC WORLD JOURNAL (2014)
Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1
Guoying Lao et al.
TUMOR BIOLOGY (2014)
Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia
Mina Kalantari et al.
VIROLOGY (2014)
PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study
Hung-Cheng Lai et al.
CANCER MEDICINE (2014)
Correlation of MCM2 detection with stage and virology of cervical cancer
Sergio Menezes Amaro Filho et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Renske D. M. Steenbergen et al.
NATURE REVIEWS CANCER (2014)
APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results
Mark H. Stoler et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
F. Carozzi et al.
BRITISH JOURNAL OF CANCER (2013)
Performance of proex c and pretect hpv-proofer e6/e7 mrna tests in comparison with the hybrid capture 2 hpv dna test for triaging ascus and lsil cytology
Reza Alaghehbandan et al.
DIAGNOSTIC CYTOPATHOLOGY (2013)
Primary Cervical Cancer Screening and Triage Using an mRNA Human Papillomavirus Assay and Visual Inspection
Lucybeth Nieves et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Multiple Human Papillomavirus Infections with High Viral Loads Are Associated with Cervical Lesions but Do Not Differentiate Grades of Cervical Abnormalities
Markus Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial
Francesca Carozzi et al.
LANCET ONCOLOGY (2013)
A COCKTAIL OF MCM2 AND TOP2A, P16INK4A AND KI-67 AS BIOMARKERS FOR THE IMPROVED DIAGNOSIS OF CERVICAL INTRAEPITHELIAL LESION
Qi-chang Yang et al.
POLISH JOURNAL OF PATHOLOGY (2013)
High-Risk Human Papillomavirus Messenger RNA Testing in Physician- and Self-Collected Specimens for Cervical Lesion Detection in High-Risk Women, Kenya
Jie Ting et al.
SEXUALLY TRANSMITTED DISEASES (2013)
Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer
Maria Lina Tornesello et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The ATHENA human papillomavirus study: design, methods, and baseline results
Thomas C. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer
Megan A. Clarke et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Cytopathic effects of human papillomavirus infection and the severity of cervical intraepithelial neoplasia : A frequency study
Nadja Lindany Alves de Sousa et al.
DIAGNOSTIC CYTOPATHOLOGY (2012)
High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: A systematic review and meta-analysis
Marielle Kocken et al.
GYNECOLOGIC ONCOLOGY (2012)
Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells
Miriam Reuschenbach et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
High-Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV-Proofer for Detection of Cervical High-Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA-Positive Women with Normal Cytology
D. C. Rijkaart et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy
Xavier Carcopino et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3
Nicolas Wentzensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian population
Nisha Thakur et al.
MOLECULAR BIOLOGY REPORTS (2012)
3q26 Amplification Is an Effective Negative Triage Test for LSIL: A Historical Prospective Study
Erica R. Heitmann et al.
PLOS ONE (2012)
E4 Antibodies Facilitate Detection and Type-Assignment of Active HPV Infection in Cervical Disease
Heather Griffin et al.
PLOS ONE (2012)
The Biology and Life-Cycle of Human Papillomaviruses
John Doorbar et al.
VACCINE (2012)
p16INK4a and p15INK4b gene promoter methylation in cervical cancer patients
Abhimanyu Kumar Jha et al.
ONCOLOGY LETTERS (2012)
Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients
Maria Benevolo et al.
CANCER CAUSES & CONTROL (2011)
p16/Ki-67 Dual-Stain Cytology in the Triage of ASCUS and LSIL Papanicolaou Cytology Results From the European Equivocal or Mildly Abnormal Papanicolaou Cytology Study
Dietmar Schmidt et al.
CANCER CYTOPATHOLOGY (2011)
Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts
Vikrant V. Sahasrabuddhe et al.
FUTURE MICROBIOLOGY (2011)
The value of p16ink4a expression by fluorescence in situ hybridization in triage for high risk HPV positive in cervical cancer screening
Wen-Jie Zeng et al.
GYNECOLOGIC ONCOLOGY (2011)
Sensitivity, Specificity, and Clinical Value of Human Papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for Cervical Cytology and HPV DNA Test
Maria Benevolo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes
D. A. M. Heideman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge
Inger Gustavsson et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Viral Load in the Natural History of Human Papillomavirus Type 16 Infection: A Nested Case-control Study
Long Fu Xi et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
C. Romagosa et al.
ONCOGENE (2011)
Differential Methylation of the HPV 16 Upstream Regulatory Region during Epithelial Differentiation and Neoplastic Transformation
Svetlana Vinokurova et al.
PLOS ONE (2011)
Is Human Papillomavirus Viral Load a Clinically Useful Predictive Marker? A Longitudinal Study
Christothea Constandinou-Williams et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?
Warner Huh et al.
GYNECOLOGIC ONCOLOGY (2010)
Current understanding of the mechanism of HPV infection
John T. Schiller et al.
GYNECOLOGIC ONCOLOGY (2010)
Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China
Carol E. Levin et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Clinical Performance of the PreTect HPV-Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer
Samuel Ratnam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Mechanisms of cell entry by human papillomaviruses: an overview
Caroline A. J. Horvath et al.
VIROLOGY JOURNAL (2010)
Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
Gaelle A. V. Boulet et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Chromosomal Signatures of a Subset of High-Grade Premalignant Cervical Lesions Closely Resemble Invasive Carcinomas
Saskia M. Wilting et al.
CANCER RESEARCH (2009)
Gain of 3q26: A genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix
Antti Seppo et al.
GYNECOLOGIC ONCOLOGY (2009)
Risk estimation for the next generation of prevention programmes for cervical cancer
Hormuzd A. Katki et al.
LANCET ONCOLOGY (2009)
Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
Koilocytosis - A cooperative interaction between the human papillomavirus E5 and E6 oncoproteins
Ewa Krawczyk et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions
Svetlana Vinokurova et al.
CANCER RESEARCH (2008)
Expression of the p16INK4a and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection
Eun Ji Nam et al.
Journal of Gynecologic Oncology (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joalim Dillner et al.
BRITISH MEDICAL JOURNAL (2008)
Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens
Irina Sokolova et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Thomas C. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?
M. Pett et al.
JOURNAL OF PATHOLOGY (2007)
Prevalence of HPV infection among females in the United States
Eileen F. Dunne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The natural history of cervical HPV infection: unresolved issues
Ciaran B. J. Woodman et al.
NATURE REVIEWS CANCER (2007)
Loss of heterozygosity at chromosome 6 as a marker of early genetic alterations in cervical intraepithelial neoplasias and microinvasive carcinomas
N. N. Mazurenko et al.
MOLECULAR BIOLOGY (2006)
Associations of high-risk HPV types and viral load with cervical cancer in China
YP Wu et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Innovation - Control of DNA replication and its potential clinical exploitation
MA Gonzalez et al.
NATURE REVIEWS CANCER (2005)
Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade
G Hudelist et al.
GYNECOLOGIC ONCOLOGY (2004)
Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRBI*1501-DQB1*0602 haplotype
H Arias-Pulido et al.
GENES CHROMOSOMES & CANCER (2004)
Clonal selection for transcriptionally active viral oncogenes during progression to cancer
BA Van Tine et al.
JOURNAL OF VIROLOGY (2004)
DNA aneuploidy and integration of human papillomavirus type 16 E6/E7 oncogenes in Intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri
P Melsheimer et al.
CLINICAL CANCER RESEARCH (2004)
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers
K Middleton et al.
JOURNAL OF VIROLOGY (2003)
Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype
K Milde-Langosch et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
p16INK4a expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation
CY Dai et al.
GASTROENTEROLOGY (2000)
分享论文
